CRLBF vs JSDA Stock Comparison

Cresco Labs and Jones Soda Prices as of Oct 26, 2026 Peers: Industry group
CRLBF Cresco Labs Inc.
$0.64 -14.7% 1M -47.5% 1Y
Market cap
$220.14M
P/E
–
Revenue (TTM)
$651.13M
Div. yield
–
Cannabis Consumer Staples
1 win
JSDA Jones Soda Co.
$0.23 -17.9% 1M +35.3% 1Y
Market cap
$26.85M
P/E
–
Revenue (TTM)
—
Div. yield
–
Non-Alcoholic Beverages Consumer Staples
3 wins

Head to Head

4 decided of 12

Jones Soda leads on 3 of the 12 questions below (Jones Soda 3, Cresco Labs 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCRLBFJSDALeader
Larger companyMarket capitalisation $220.14M $26.85M CRLBF
Cheaper on earningsLower P/E, profitable companies only -2.1x -15.1x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — — –
Faster revenue growthRevenue growth, trailing twelve months -5.0% — –
More profitableNet margin, trailing twelve months -16.1% — –
Better return on capitalReturn on invested capital -4.4% — –
Less leveragedLower net debt / EBITDA 22.4x — –
Higher dividend yieldTrailing dividend yield 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months -47.5% +35.3% JSDA
Better 5-year returnAnnualised price return, 5 years -39.1%/yr -23.7%/yr JSDA
Less volatileAnnualised volatility, 1 year 122.9% 93.6% JSDA
Higher overall scoreMean of the five percentile scores vs peers 37/100 — –

Percentile Scorecard

CRLBFJSDA

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCRLBFJSDA
Valuation 73 #11 of 38 –
Growth 9 #32 of 35 97 #2 of 33
Profitability 51 #18 of 36 –
Financial Health 16 #33 of 39 –
Shareholder Returns – –
Overall 37 –
  • CRLBF ranked among 40 companies in Tobacco and Cannabis
  • JSDA ranked among 41 companies in Beverages

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCRLBFJSDASPY
1 month -14.7%-17.9% -0.8%
3 months -5.9%-23.3% +3.5%
6 months -46.2%-14.8% +7.0%
Year to date -48.0%-17.9% +12.2%
1 year -47.5%+35.3% +13.0%
3 years -44.8%+35.3% +86.3%
3 years, per year -18.0%+10.6% +23.1%
5 years -91.6%-74.2% +68.6%
5 years, per year -39.1%-23.7% +11.0%
10 years —-42.5% +258.0%
10 years, per year —-5.4% +13.6%

Risk

MeasureCRLBFJSDASPY
Volatility, 1Y 122.9%93.6% 12.7%
Downside volatility, 1Y 112.3%102.8% 12.7%
Beta vs S&P 500, 1Y 1.510.27 1.00
Return / volatility, 1Y -0.390.38 1.02
Max drawdown, 5Y -95.5%-87.6% -25.4%
From 52-week high -66.7%-39.5% -1.8%
52-week high $1.92$0.38 $779.14
52-week low $0.59$0.17 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCRLBFJSDA
P/E now vs peer median -2.2xmedian 16.5x -15.1xmedian 26.6x
P/S now vs peer median 0.3xmedian 0.9x —median 1.5x
EV/EBITDA now vs peer median 35.1xmedian 12.3x —median 14.2x
P/FCF now vs peer median 36.4xmedian 23.1x —median 18.3x
P/B now vs peer median 0.9xmedian 1.0x —median 2.6x
PEG now vs peer median -0.07median 0.56 -0.39median 2.09

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCRLBFJSDA
Revenue $651.13M –
Gross profit $325.08M –
Operating income -$33.18M –
Net income -$112.56M -$7.00K
Free cash flow $6.24M –
EPS (diluted) $-0.30 $-0.02
Cash & equivalents $32.87M –
Total debt $1.76B –
Shares (diluted) 355.01M 116.81M
Enterprise value $51.61M $26.85M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCRLBFJSDA
P/E -2.2x -15.1x
P/FCF 36.4x –
P/Operating cash flow 5.2x –
P/S 0.3x –
P/B 0.9x –
P/Tangible book -3.9x –
EV/EBITDA 35.1x –
EV/EBIT -18.8x –
EV/Revenue 1.0x –
EV/FCF 100.3x –
EV/Operating cash flow 14.4x –
PEG (3Y EPS CAGR) -0.07 -0.39

Growth

14 metrics
MetricCRLBFJSDA
Revenue growth (1Y) -5.0% –
Revenue CAGR (3Y) -6.7% –
Gross profit growth (1Y) -4.2% –
Gross profit CAGR (3Y) -3.3% –
Operating income growth (1Y) -144.0% –
Operating income CAGR (3Y) 37.3% –
Net income growth (1Y) -123.6% 99.9%
Net income CAGR (3Y) 23.9% 89.7%
EPS growth (1Y) -150.2% 83.5%
EPS CAGR (3Y) 29.6% 39.0%
Operating cash flow growth (1Y) -63.3% –
Operating cash flow CAGR (3Y) 2.6% –
Free cash flow growth (1Y) -95.7% –
Free cash flow CAGR (3Y) -62.6% –

Profitability

14 metrics
MetricCRLBFJSDA
Gross margin 49.9% –
EBITDA margin 2.7% –
Operating margin -5.1% –
Pretax margin -15.9% –
Net margin -16.1% –
FCF margin 1.0% –
Operating cash flow margin 6.7% –
Return on equity -59.3% –
Return on assets -12.2% –
Return on invested capital -4.4% –
Return on capital employed -3.0% –
Asset turnover 0.5x –
Cash conversion (OCF / net income) -0.4x –
Stock comp / revenue 2.3% –

Financial Health

11 metrics
MetricCRLBFJSDA
Debt / assets 34.1% –
Debt / equity 1.6x –
Net debt / EBITDA 22.4x –
Debt / FCF 69.1x –
Liabilities / assets 79.2% –
Equity / assets 20.8% –
Interest coverage – –
Current ratio 1.8x –
Quick ratio 0.5x –
Cash ratio 0.2x –
Altman Z-score -0.99 –

Shareholder Returns

7 metrics
MetricCRLBFJSDA
Dividend yield – –
Net buyback yield – –
Shareholder yield – –
Payout ratio (earnings) – –
Payout ratio (FCF) – –
Dividend growth (1Y) – –
Dividend CAGR (3Y) – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCRLBFJSDA
EPS, next fiscal year $-0.03FY2026 –
Revenue, next fiscal year $637.07MFY2026 –
Revenue growth, next FY -2.9%FY2026 –
Revenue growth, the year after +3.0% –

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCRLBFJSDA
Held by institutions 0.0% –
Institutions holding 6 –
Change in shares held, QoQ -17.9% –
Institutions buying 2 –
Institutions selling 0 –
Buyers to sellers – –

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CRLBFJSDA
CRLBF 1.00 0.09
JSDA 0.09 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CRLBF and JSDA?

Cresco Labs (CRLBF) is the largest by market capitalisation: Cresco Labs (CRLBF) $220.14M, Jones Soda (JSDA) $26.85M.

Which stock has performed better?

Over the past year Jones Soda (JSDA) returned the most: Cresco Labs (CRLBF) -47.5%, Jones Soda (JSDA) +35.3%. Over five years, Jones Soda (JSDA) compounded fastest (Cresco Labs (CRLBF) -39.1%/yr, Jones Soda (JSDA) -23.7%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Jones Soda (JSDA) has been the steadiest (Cresco Labs (CRLBF) 122.9%, Jones Soda (JSDA) 93.6%). Volatility measures how widely the price swings, not the risk of the business.

Do CRLBF and JSDA move together?

Their daily returns over the past year have a correlation of 0.09, a weak relationship. Holding both diversifies more than two closely linked stocks would.

Which is the better stock, CRLBF and JSDA?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Jones Soda (JSDA) leads on 3. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.